Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Treatment With Xeomin, Radiesse, and Belotero for Improvement in Photoaging and Skin Quality

NCT05039723 is registered in ClinicalTrials.gov with Main Line Center for Laser Surgery as lead sponsor.

NCT NCT05039723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05039723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Treatment With Xeomin, Radiesse, and Belotero for Improvement in Photoaging and Skin Quality
Lead sponsor
Main Line Center for Laser Surgery
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2021
Completion date
July 1, 2022
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

photoaging